Navigation Links
Varian Medical Systems to Equip New Proton Treatment Center in Russia
Date:2/16/2012

PALO ALTO, Calif., Feb. 16, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced it has booked an order to equip a new two-room proton therapy center at the PTC St. Petersburg Center of Nuclear Medicine of the International Institute of Biological Systems in Russia.  The equipment order was placed by Owen Kane Oncology Equipment, Inc. in New York which is supplying the system to the center in St. Petersburg. 

Under the purchase agreement Varian will equip the new center with a ProBeam™ system as well as its ARIA information management and Eclipse treatment planning software products.  The equipment order is valued at about $50 million not including service.  Equipment delivery and installation is expected to commence in 2014 and patient treatments are scheduled to begin in 2016. 

"We're very pleased to be able to bring Varian's cutting edge, clinically advanced and reliable technology to patients," said Dr. Arkadi Stolpner, President of the International Institute of Biological Systems Diagnostic and Treatment Center.  "Our aim in purchasing the Varian ProBeam system is to help us meet our mission of saving lives."

"We are honored to be a part of a very important project that will help to make the most advanced proton therapy available to the people of Russia," said Tim Guertin, President and CEO of Varian Medical Systems.  "The ProBeam system combines Varian's unmatched technology for intensity modulated proton therapy with advanced imaging, treatment planning, and information management capabilities that have been developed on the basis of decades of experience in clinical support.  This is another exciting step forward for proton therapy."

"We selected Varian to supply our Proton Beam technology because we have confidence in their ability to deliver a quality product on a timely ba
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 In response to ... Association of Sierra Leone , Direct Relief ... for the treatment of local health workers who ... a new dedicated Ebola care center was constructed for foreign ... facility is not available for local Sierra Leonean health workers. ...
(Date:12/22/2014)... NxStage Medical, Inc. (NASDAQ: NXTM ... announced today that the U.S. Food and Drug ... perform hemodialysis overnight while the patient is at ... System One is the first and only hemodialysis ... Home nocturnal hemodialysis is an ...
(Date:12/22/2014)... Research and Markets ( http://www.researchandmarkets.com/research/hmlfbq/investment ... "Investment Analysis of the US Medical Device Sector ... http://photos.prnewswire.com/prnh/20130307/600769 This ... sector identifies the key trends and rationale for ... mergers and acquisitions. The study will ...
Breaking Medicine Technology:First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3Investment Analysis of the US Medical Device Sector 2
... new approach to research, along with public policies that ... diseases with potentially devastating personal and financial consequences, such ... Ph.D., chairman, president and CEO of Eli Lilly and ... Thursday in London during a keynote address at The ...
... Mass., Feb. 9, 2011 New England Biolabs ... Journal of Visualized Experiments (JoVE) for the EpiMark™ ... suite of new and validated products designed to ... protocol describes a 3-step, PCR-based assay to identify ...
Cached Medicine Technology:Lilly CEO Says Industry, Public Policy Must Pave Way For Innovation 2Lilly CEO Says Industry, Public Policy Must Pave Way For Innovation 3New England Biolabs Releases JoVE Video Protocol Highlighting Assay to Quantitate 5-hmC in Epigenome 2
(Date:12/26/2014)... 26, 2014 Parker & Sons, ... best in heating, cooling and plumbing contractor services ... emergency services in 2014 with regard to air-conditioning ... Arizona is known for its incredibly hot summers. ... the intricacies and details of a wide variety ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
(Date:12/25/2014)... 2014 The short film “Color of Honor” ... honor of a true 9/11 hero, Welles Remy Crowther. It ... the 24 hours of Nuremberg International Short Film Festival and ... Actress, screenwriter and director Luciana Lagana plays the ... with her husband, Gregory Graham - Graham plays ...
(Date:12/25/2014)... December 25, 2014 Recently, LunaDress.co.uk has updated its ... and related accessories. Now, all of the models at LunaDress.co.uk come ... a groom lifts the wedding veil can turn out to be ... charm. A wedding veil can always bring surprise to a wedding. ... on how to choose veils for a big day . ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... could be closing in on a "fountain of youth" drug ... health of older adults, a new study suggests. Seniors ... a drug that targets a genetic signaling pathway linked to ... report. The experimental medication, a version of ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3
... Netherlands, May 8 LyondellBasell Industries,has completed ... of its management systems at its plants ... MonoPropyleneGlycol USP/EP,(MPG-USP/EP) is produced., HACCP is ... preventing,food safety hazards. The comprehensive nature of ...
... 8 PennWell Corporation is launching a,third dental ... -,7th, 2008. Registration is now open and available ... use,leading-edge technology to bring dental professionals together with,colleagues ... computer., "DDS Tech Fair is designed to ...
... Academies Keck FUTURES INITIATIVE announced today the recipients of ... research on aging and healthspan -- the period of ... The 15 projects chosen represent a wide range ... of the fifth annual FUTURES conference, "The Future of ...
... physicians across the country who lead small practices are ... FACP, president of the American College of Physicians (ACP) ... Dr. Dale emphasized that practices are medicines small businesses, ... Medicares flawed reimbursement rates and formulas. , Approximately 20 ...
... non-profit youth,development organization, has been awarded a $25,000 grant ... launched Healthy Communities Program,launched today in conjunction with District ... General Mills Foundation and the Mayor,s Commission,on Food and ... to focus on,helping children eat healthy and stay physically ...
... people discover mold on their bread, they immediately throw ... the tiny fungus. A University of Missouri scientist, along ... mechanism in the reproductive cycle of a certain species ... abnormalities by silencing unmatched genes during meiosis (sexual reproduction). ...
Cached Medicine News:Health News:Raising the Bar on MonoPropyleneGlycol USP/EP 2Health News:PennWell Announces DDS Tech Fair 2Health News:Keck Futures Initiative awards $1M for 15 research projects 2Health News:Keck Futures Initiative awards $1M for 15 research projects 3Health News:Keck Futures Initiative awards $1M for 15 research projects 4Health News:Keck Futures Initiative awards $1M for 15 research projects 5Health News:Keck Futures Initiative awards $1M for 15 research projects 6Health News:ACP says Medicare cuts will hurt physicians in small practices 2Health News:Brainfood Awarded $25,000 Grant from General Mills Foundation through DC Mayor Fenty's New Health Communities Program 2Health News:Bread mold may hold secret to eliminating disease-causing genes 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: